Evidence map›Paper›PMID 42666841›Full record

ArticleFrontiers in immunology2026

Comparative analysis of microbiota in the ocular surface of patients with atopic keratoconjunctivitis and Stevens-Johnson Syndrome with severe ocular complications.

Mayumi Ueta, Ka Man Tse, Hinako Nanri, Hiromi Nishigaki, Yoshihiro Takai, Takayuki Jujo Sanada, Hitoshi Kawashima, Koji Hosomi, Takayuki Miyano, Tsuyoshi Ishii and 2 more

Abstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mayumi Ueta *Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ka Man Tse *ROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
Hinako NanriLaboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Hiromi NishigakiDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yoshihiro TakaiROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
Takayuki Jujo Sanada *Laboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Hitoshi KawashimaLaboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Koji HosomiLaboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Takayuki MiyanoROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
Tsuyoshi IshiiROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
Chie SotozonoDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Jun KunisawaLaboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The interplay between host immunity and the microbiome is increasingly recognized as an important factor in ocular surface diseases. Although cutaneous and intestinal dysbiosis have been implicated in atopic dermatitis (AD), the role of the ocular microbiome in its severe ophthalmic manifestation, atopic keratoconjunctivitis (AKC), remains incompletely understood. Methods: We performed 16S rRNA gene sequencing to characterize the ocular and fecal microbiota of patients with AD and severe AKC, AD without severe ocular involvement, Stevens-Johnson syndrome (SJS) with severe ocular complications (SOC), and healthy controls. Microbial community composition was compared using principal coordinate analysis (PCoA) and taxonomic profiling. Results: Ocular microbiota composition differed among the study groups. PCoA demonstrated that SJS samples clustered separately from healthy controls, whereas AKC samples occupied an intermediate position between the healthy control and SJS groups. Taxonomic analysis revealed enrichment of Corynebacterium 1 (a SILVA genus-level taxonomic assignment) in SJS, while AKC samples exhibited increased relative abundances of both Corynebacterium 1 and Staphylococcus. In contrast, AD patients without severe ocular involvement maintained an ocular microbial community broadly similar to that of healthy controls, including the presence of Neisseria. Analysis of paired fecal samples did not reveal disease-associated clustering or major compositional differences among the study groups. Discussion: These findings suggest that, using genus-level 16S rRNA sequencing, disease-associated microbial alterations are more readily detected on the ocular surface than in the fecal microbiome in this cohort. The results support a potential contribution of the local ocular microenvironment to microbial signatures associated with immune-mediated ocular surface inflammation and provide a framework for future studies investigating the role of the ocular microbiome in disease pathogenesis.

Indexed as

KeratoconjunctivitisMicrobiotaStevens-Johnson SyndromeAdolescentAdultBacteriaDermatitis, AtopicFecesFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SSkin MicrobiomeYoung AdultRNA, Ribosomal, 16Satopic dermatitisatopic keratoconjunctivitisdysbiosisgut-eye axismicrobiomeStevens-Johnson Syndrome

Identifiers

PMID42666841
PMCPMC13523246

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.